Teleflex (TFX) Stock
Key stats
- Market cap
- $6.45B
- Price / Earnings ratio
- -6.2x
- EPS (TTM)
- -$23.28
- Volume
- Loading
- 52-week high
- $150.04
- 52-week low
- $100.18
- Dividend yield
- 0.89%
- Dividend amount (latest)
- $0.34
- EPS vs analyst estimate
- +8.6%Q3 FY25 · $3.67 vs $3.38
Source: third-party data provider, as of November 7, 2026
EPS estimate: analyst consensus
Compare with TFX
Recent news

Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
TFX

Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
TFX

Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
TFX

TFX or SONVY: Which Is the Better Value Stock Right Now?
TFX or SONVY: Which Is the Better Value Stock Right Now?
TFX
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 79.71
- MACD 12/26/9
- 4.91
- EMA 9 of MACD
- 3.11
- MACD histogram
- 1.81
- SMA 50
- $131.87
- Price above SMA 50
- EMA 50
- $133.59
- Price above EMA 50
- SMA 200
- $126.02
- Price above SMA 200
- EMA 200
- $126.02
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 6 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $3.98 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
TFX

Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
TFX

Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
TFX

TFX or SONVY: Which Is the Better Value Stock Right Now?
TFX or SONVY: Which Is the Better Value Stock Right Now?
TFX

Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
TFX

Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
TFX

Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
TFX

Here's Why Teleflex (TFX) is a Strong Value Stock
Here's Why Teleflex (TFX) is a Strong Value Stock
TFX

5 Low P/B Stocks That Offer Attractive Value and Growth
5 Low P/B Stocks That Offer Attractive Value and Growth
TFX

TFX vs. PEN: Which Stock Is the Better Value Option?
TFX vs. PEN: Which Stock Is the Better Value Option?
TFX
News tone: automated (AI) classification of the article's content, not a price prediction.
About Teleflex
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jason Weidman | President, CEO & Director | — |
| Mr. John R. Deren | Executive VP & CFO | 1968 |
| Mr. Daniel V. Logue J.D. | Corporate VP, General Counsel & Secretary | 1974 |
| Mr. Cameron P. Hicks | Corporate Vice President of Human Resources & Communications | 1965 |
| Mr. Timothy F. Duffy | VP & Chief Information Officer | — |
| Mr. Lawrence Soren Keusch | Vice President of Investor Relations & Strategy Development | — |
| Mr. Howard Cyr | Corporate VP & Chief Compliance Officer | — |
| Mr. Matt Tomkin | Vice President of Corporate Development | — |
| Mr. James Ferguson | President & GM of Surgical | — |
| Mr. Jake Newman | President & GM of Vascular and Emergency Medicine | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 79.71
- MACD 12/26/9
- 4.91
- EMA 9 of MACD
- 3.11
- MACD histogram
- 1.81
- SMA 50
- $131.87
- Price above SMA 50
- EMA 50
- $133.59
- Price above EMA 50
- SMA 200
- $126.02
- Price above SMA 200
- EMA 200
- $126.02
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
6 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $142.00
- Average
- $157.83
- High
- $170.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -15.6 | +13.5 | ||||||||||
| 2022 | -7.3 | +8.7 | +6.5 | -19.5 | +1.8 | -13.1 | -5.7 | -7.8 | -11.1 | +2.9 | +6.8 | +2.0 |
| 2023 | -2.6 | -4.8 | +8.4 | +8.2 | -14.4 | +3.5 | +5.2 | -14.7 | -8.0 | -5.7 | +20.4 | +9.5 |
| 2024 | -3.0 | -10.0 | +1.4 | -6.3 | -1.2 | -2.1 | +4.5 | +3.9 | +1.0 | -18.0 | -8.7 | -8.4 |
| 2025 | +0.7 | -24.2 | +2.3 | -2.3 | -2.9 | -1.1 | -1.9 | +9.1 | -3.7 | +0.4 | -6.9 | +6.7 |
| 2026 | -14.7 | +18.1 | -2.7 | +4.6 | +5.6 | -0.6 | +5.4 | +1.7 | -11.0 | +10.8 | +8.2 |




